Inventor · disambiguated record
Mark A. Nagy
Also filed as: NAGY MARK A
25 granted patents·14 pending applications·142 citations·filing 2003–2024
95Inventor score
Files withCELGENE CORP14SIGNAL PHARM LLC10TREELINE BIOSCIENCES INC6SIGNAL PHARMACEUTICAL LLC3BENNETT BRYDON L1
Top patents by PatentIndex Score
39 records- 0196US11185543B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2020·Granted Nov 30, 2021·5 cites·20 claims
- 0296US11149007B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted Oct 19, 2021·14 cites·41 claims
- 0396US9701643B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Jul 11, 2017·19 cites·18 claims
- 0495US10357489B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2018·Granted Jul 23, 2019·20 cites·26 claims
- 0594US11325889B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted May 10, 2022·11 cites·35 claims
- 0694US10040770B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2017·Granted Aug 7, 2018·7 cites·18 claims
- 0794US9139534B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithBENNETT BRYDON L·Filed 2012·Granted Sep 22, 2015·30 cites·76 claims
- 0893US11873283B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Jan 16, 2024·2 cites·34 claims
- 0993US10266500B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2018·Granted Apr 23, 2019·5 cites·14 claims
- 1092US11325890B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2020·Granted May 10, 2022·2 cites·18 claims
- 1188US2025000860A1Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2024·Application pending·0 cites
- 1286US10919865B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2019·Granted Feb 16, 2021·3 cites·16 claims
- 1383US9428509B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2014·Granted Aug 30, 2016·6 cites·32 claims
- 1483US9346812B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2014·Granted May 24, 2016·6 cites·30 claims
- 1582US11358952B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted Jun 14, 2022·1 cites·21 claims
- 1682US2024207255A1Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2024·Application pending·0 cites
- 1781US12404241B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2023·Granted Sep 2, 2025·0 cites·16 claims
- 1880US12129237B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2022·Granted Oct 29, 2024·0 cites·6 claims
- 1980US2024217955A1Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2024·Application pending·0 cites
- 2079US7119203B2Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2003·Granted Oct 10, 2006·11 cites·2 claims
- 2179US2022378785A1Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2021·Application pending·0 cites
- 2277US12029738B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2021·Granted Jul 9, 2024·0 cites·23 claims
- 2377US11945804B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 2475US11241430B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2019·Granted Feb 8, 2022·0 cites·11 claims
- 2573US2024208937A1Compounds and Their Use for Treatment of HemoglobinopathiesBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2671US10517873B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2019·Granted Dec 31, 2019·0 cites·3 claims
- 2769US10675281B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2019·Granted Jun 9, 2020·0 cites·20 claims
- 2868US12486281B2Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Granted Dec 2, 2025·0 cites·25 claims
- 2968US2024287091A1Tricyclic quinolone bcl6 bifunctional degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3068US2025276981A1Tricyclic quinolone bcl6 bifunctional degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3164US2025282771A1Tetrahydroisoquinoline heterobifunctional bcl-xl degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3264US2025288683A1Tetrahydroisoquinoline heterobifunctional bcl-xl degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3363US2024238423A9Tetrahydroisoquinoline heterobifunctional bcl-xl degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3460US2025270191A1Quinolone bcl6 bifunctional degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3559US11306101B2Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2020·Granted Apr 19, 2022·0 cites·35 claims
- 3653US9795607B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2016·Granted Oct 24, 2017·0 cites·33 claims
- 3751US2006074243A1Hydroxamic acid and amide compounds and their use as protease inhibitorsPHARMACIA ITALIA SPA·Filed 2005·Application pending·0 cites
- 3849US2004167182A1Hydroxamic acid and amide compounds and their use as protease inhibitorsFiled 2003·Application pending·0 cites
- 3945US2004142979A1Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitorsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark A. Nagy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →